top of page

How can we improve our understanding of the progression of myeloma?

Irene Ghobrial, MD of the Dana-Farber Cancer Institute (DFCI), Boston, MA, discusses the progression of multiple myeloma (MM), which comes from precursor conditions such as monoclonal gammopathy of undetermined significance (MGUS) and smoldering myeloma. It is not known, however, which patients will progress. +watch video


Commenting has been turned off.
bottom of page